Cargando…

Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation

Programmed cell death ligand 1 (PD-L1) expression is an important biomarker for predicting response to immunotherapy in clinical practice. Hence, identification and characterization of factors that predict high expression of PD-L1 in patients is critical. Various studies have reported the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Seung Eun, Kim, Yu Jin, Sung, Minjung, Lee, Mi-Sook, Han, Joungho, Kim, Hong Kwan, Choi, Yoon-La
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801455/ https://www.ncbi.nlm.nih.gov/pubmed/31561631 http://dx.doi.org/10.3390/ijms20194794

Ejemplares similares

Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers
por: Lee, Boram, et al.
Publicado: (2016)

Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
por: Lee, Taebum, et al.
Publicado: (2016)

Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer
por: Kim, Yujin, et al.
Publicado: (2020)

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma
por: Zhou, Wensheng, et al.
Publicado: (2022)

Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma: A single‐institute experience of 10 cases
por: Cho, Yoon Ah, et al.
Publicado: (2020)

Real-World Analysis of the EGFR Mutation Test in Tissue and Plasma Samples from Non-Small Cell Lung Cancer
por: Lee, Hyunwoo, et al.
Publicado: (2021)

The High Proportion of Discordant EGFR Mutations among Multiple Lung Tumors
por: Lee, Hyunwoo, et al.
Publicado: (2022)

Usual Interstitial Pneumonia with Lung Cancer: Clinicopathological Analysis of 43 Cases
por: Song, Dae Hyun, et al.
Publicado: (2014)

Clinicopathological parameters for circulating tumor DNA shedding in surgically resected non-small cell lung cancer with EGFR or KRAS mutation
por: Cho, Min-Sun, et al.
Publicado: (2020)

Recent Trends in Demographics, Surgery, and Prognosis of Patients with Surgically Resected Lung Cancer in a Single Institution from Korea
por: Yun, Jae Kwang, et al.
Publicado: (2019)

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer
por: Nishii, Teppei, et al.
Publicado: (2014)

Changes in PD-L1 expression according to tumor infiltrating lymphocytes of acquired EGFR-TKI resistant EGFR-mutant non-small-cell lung cancer
por: Kim, Tae-Jung, et al.
Publicado: (2017)

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases
por: Ahn, Soomin, et al.
Publicado: (2016)

EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
por: Jo, Ukhyun, et al.
Publicado: (2014)

MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
por: Kim, Hyojin, et al.
Publicado: (2016)

The New 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Resected Specimens: Clinicopathologic Relevance and Emerging Issues
por: Ha, Seung Yeon, et al.
Publicado: (2013)

EGFR Mutation Detection and Its Association With Clinicopathological Characters of Lung Cancer Patients
por: Gaur, Priyanka, et al.
Publicado: (2018)

Clinicopathological features of patients with transformation from EGFR mutant lung adenocarcinoma to small cell lung cancer
por: Bai, Wenwen, et al.
Publicado: (2021)

PD‐L1 expression in ROS1‐rearranged non‐small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1
por: Lee, Jongmin, et al.
Publicado: (2018)

Outcome of Limited Resection for Lung Cancer
por: Cho, Jeong Su, et al.
Publicado: (2011)

Study of the clinicopathological features of soluble PD-L1 in lung cancer patients
por: Sasaki, Takanobu, et al.
Publicado: (2023)

Clinicopathological features of resected pediatric congenital lung and mediastinal lesions: A single institution experience
por: Al Jadaan, Saud A., et al.
Publicado: (2021)

CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas
por: Woo, Jung Han, et al.
Publicado: (2020)

Synchronous Triple Primary Lung Cancers: A Case Report
por: Yoon, Hyun Jung, et al.
Publicado: (2014)

The prognostic implications of EGFR mutation and ALK rearrangement for the long‐term outcomes of patients with resected lung adenocarcinomas
por: Kim, Hyungjin, et al.
Publicado: (2019)

Clathrin‐mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild‐type EGFR non‐small cell lung cancer
por: Kim, Boyeon, et al.
Publicado: (2020)

Clinicopathological Characteristics of Colon Cancer Diagnosed at Primary Health Care Institutions
por: Park, Sang Hyun, et al.
Publicado: (2014)

NTRK Fusions in 1113 Solid Tumors in a Single Institution
por: Bang, Heejin, et al.
Publicado: (2022)

Associations of TIMP-3 Genetic Polymorphisms with EGFR Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients
por: Chang, Jer-Hwa, et al.
Publicado: (2020)

Diagnostic and Predictive Values of (18)F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma
por: Hong, Il Ki, et al.
Publicado: (2020)

High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy
por: Yoon, Byung Woo, et al.
Publicado: (2020)

Radiologic Progression of Interstitial Lung Abnormalities following Surgical Resection in Patients with Lung Cancer
por: Shin, Yoon Joo, et al.
Publicado: (2023)

Prognostic Prediction Models Based on Clinicopathological Indices in Patients With Resectable Lung Cancer
por: Liu, Yanyan, et al.
Publicado: (2020)

Natural Progression of Ground-glass Nodules after Curative Resection for Non-small Cell Lung Cancer
por: Lee, Kanghoon, et al.
Publicado: (2021)

Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy
por: Yu, Li, et al.
Publicado: (2022)

Prognostic significance of extranodal extension in patients with pathologic N1 non-small cell lung cancer undergoing complete resection
por: Yoon, Seung Keun, et al.
Publicado: (2023)

Relationship of the lung microbiome with PD-L1 expression and immunotherapy response in lung cancer
por: Jang, Hye Jin, et al.
Publicado: (2021)

Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non–Small Cell Lung Cancer
por: Lee, Chaelin, et al.
Publicado: (2022)

The single institutional outcome of postoperative radiotherapy and concurrent chemoradiotherapy in resected non-small cell lung cancer
por: Lee, Hyo Chun, et al.
Publicado: (2014)

Intronic variant of EGFR is associated with GBAS expression and survival outcome of early‐stage non‐small cell lung cancer
por: Hong, Mi Jeong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6gri9b0i81q587pu65n8p0ppel